Related Experiment Video
Updated: Jul 12, 2025

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2
Ho Gyun Lee1, Il Hyeon Jung1, Byong Seo Park1
1Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.
Backgruound:
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are currently used to treat patients with diabetes. Previous studies have demonstrated that treatment with SGLT-2 inhibitors is accompanied by altered metabolic phenotypes. However, it has not been investigated whether the hypothalamic circuit participates in the development of the compensatory metabolic phenotypes triggered by the treatment with SGLT-2 inhibitors.
Methods:
Mice were fed a standard diet or high-fat diet and treated with dapagliflozin, an SGLT-2 inhibitor. Food intake and energy expenditure were observed using indirect calorimetry system. The activity of hypothalamic neurons in response to dapagliflozin treatment was evaluated by immunohistochemistry with c-Fos antibody. Quantitative real-time polymerase chain reaction was performed to determine gene expression patterns in the hypothalamus of dapagliflozin-treated mice.
Results:
Dapagliflozin-treated mice displayed enhanced food intake and reduced energy expenditure. Altered neuronal activities were observed in multiple hypothalamic nuclei in association with appetite regulation. Additionally, we found elevated immunosignals of agouti-related peptide neurons in the paraventricular nucleus of the hypothalamus.
Conclusion:
This study suggests the functional involvement of the hypothalamus in the development of the compensatory metabolic phenotypes induced by SGLT-2 inhibitor treatment.
Insights
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors alter metabolism. This study reveals the hypothalamus plays a key role in these compensatory metabolic changes, influencing appetite regulation in mice treated with SGLT-2 inhibitors.
Area of Science:
- Metabolic Phenotyping
- Neuroendocrinology
- Pharmacology
Background:
- Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are established diabetes treatments.
- SGLT-2 inhibitor therapy is linked to altered metabolic phenotypes.
- The role of the hypothalamus in these adaptive metabolic changes remains unexplored.
Purpose of the Study:
- To investigate the involvement of the hypothalamic circuit in compensatory metabolic phenotypes induced by SGLT-2 inhibitor treatment.
- To elucidate the neural mechanisms underlying metabolic adaptations to SGLT-2 inhibition.
Main Methods:
- Mice were administered dapagliflozin, an SGLT-2 inhibitor, under standard or high-fat diet conditions.
- Indirect calorimetry assessed food intake and energy expenditure.
- Immunohistochemistry and quantitative real-time PCR analyzed hypothalamic neuronal activity and gene expression.
Main Results:
- Dapagliflozin treatment led to increased food intake and decreased energy expenditure in mice.
- Neuronal activity in appetite-regulating hypothalamic nuclei was altered.
- Elevated agouti-related peptide neuron activity was observed in the paraventricular nucleus.
Conclusions:
- The hypothalamus is functionally involved in the development of metabolic phenotypes associated with SGLT-2 inhibitor therapy.
- These findings highlight the central role of the hypothalamus in mediating adaptive metabolic responses to SGLT-2 inhibition.
More Related Videos
11:10Membrane Potential Dye Imaging of Ventromedial Hypothalamus Neurons From Adult Mice to Study Glucose Sensing
Published on: November 27, 2013
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Secondary Active Transport
Glucose Absorption Into the Small Intestine
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Regulation of Food Intake
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...